| Joni Larson, | |
|
201 S Lloyd St, Ste E201, Aberdeen, SD 57401-4552 | |
| (605) 622-2545 | |
| (605) 622-2531 |
| Full Name | Joni Larson |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 201 S Lloyd St, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356740781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LPC-MH2239 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joni Larson, Po Box 1460, Aberdeen, SD 57402-1460 Ph: (605) 622-2857 | Joni Larson, 201 S Lloyd St, Ste E201, Aberdeen, SD 57401-4552 Ph: (605) 622-2545 |
News Archive
Curemark LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at three additional clinical trial sites.
AdvanSource Biomaterials Corporation,a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced it was notified by the staff of the NYSE Amex that a review of the Company's Form 10-Q for the period ended June 30, 2010 indicated that the Company is not in compliance with one of the NYSE Amex's continued listing standards as set forth in Part 10 of the NYSE Amex's Company Guide (the "Company Guide").
Boehringer Ingelheim announced today that the first results of the two confirmatory Phase III INPULSISTM trials, investigating nintedanib* in the treatment of idiopathic pulmonary fibrosis (IPF), will be presented at the 2014 American Thoracic Society (ATS) International Conference taking place 16 - 21 May in San Diego
Bacteria that cause pneumonic plague can evade our first-line defences, making it difficult for the body to fight infection. In fact, a signature of the plague is the lack of an inflammatory response. Now, scientists have discovered a way to protect against death following infection with plague bacteria, by using molecules that can mimic the pathogens. According to research published in the July issue of Microbiology, these molecules make antibiotics more effective and can even be used to protect against other diseases.
› Verified 7 days ago
Taylor A Petersen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14 S Main St Ste 1e, Aberdeen, SD 57401 Phone: 605-225-1010 Fax: 605-725-8055 | |
Madalyn Pederson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14 S Main St Ste 1e, Aberdeen, SD 57401 Phone: 605-225-1010 | |
Sheila Snover, Counselor Medicare: Not Enrolled in Medicare Practice Location: 628 Circle Dr, Aberdeen, SD 57401 Phone: 605-225-1010 Fax: 605-725-8057 | |
Amy L Hauge, LPC-MH, QMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 125 Railroad Ave Se Ste 1, Aberdeen, SD 57401 Phone: 605-725-5505 | |
Nancy Yada, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14 S Main St, Suite 1e, Aberdeen, SD 57401 Phone: 605-225-1010 Fax: 605-225-1017 | |
Reagan M Flamboe, Counselor Medicare: Medicare Enrolled Practice Location: 14 S Main St, Suite 1e, Aberdeen, SD 57401 Phone: 605-225-1010 Fax: 605-225-1017 | |
Megan Hulke, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14 S Main St Ste 1e, Aberdeen, SD 57401 Phone: 605-725-4956 Fax: 605-725-8055 |